FDA to fast-track review of application to allow NARCAN to be sold over the counter
(The Center Square) – The U.S. Food and Drug Administration accepted Emergent BioSolutions' request to review its supplemental New Drug Application for the NARCAN® Nasal Spray to be sold as an over-the-counter emergency treatment for known or suspected opioid overdose, the company said Tuesday.
Source: washingtonexaminer.com
